As part of its CSR policy and its commitment “to be useful for human health”, Stem Genomics is taking action to support the 2025 Telethon, a fundraising event which brought rare diseases out of scientific and medical obscurity. This annual event is led by the French Muscular Dystrophy Association (AFM-Telethon), an association of activists, patients and parents of patients affected by rare, progressive and significantly disabling genetic diseases, known as genetic neuromuscular diseases.
This cause is particularly close to our hearts, as the I-Stem laboratory was one of our very first customers in 2018, when the company was founded. A true pioneer in cell therapy in France, I-Stem was created by the AFM-Telethon in partnership with INSERM and is dedicated to cell therapy for monogenic diseases. The laboratory conducts research and development activities using stem cells in two areas, namely cell therapy and high-throughput pharmacological screening using cells modelling pathologies. Its work involves diseases of the muscle, the motor neurons, the skin, the retina and diseases associated with developmental anomalies of the central nervous system. Today it boasts more than 75 experts.
Thanks to donations, the AFM-Telethon funds more than 350 research programs each year. These programs support over 2,000 experts and researchers worldwide. Currently, 40 human treatment trials are underway or being prepared for 33 different diseases, including muscle, skin, heart, vision, and liver diseases. Additionally, millions of euros are spent on helping families and patients in their daily lives.
Support this work by making a generous donation to help researchers fight disease. Thank you in advance—we are counting on you!
Follow us on social media during our Téléthon campaign:
On LinkedIn:linkedin.com/company/stemgenomics
On Instagram: @stemgenomics
